Cronos (CRON) Cash & Current Investments (2016 - 2026)
Cronos (CRON) recorded quarterly Cash & Current Investments of $821.9 million in Q1 2026, down 1.19% quarter-over-quarter from $831.8 million in Q4 2025, and down 1.91% on a YoY basis from $837.8 million in Q1 2025.
Cronos (CRON) Cash & Current Investments (2016 - 2026) Analysis & Trends
Cronos' Cash & Current Investments history runs 11 years deep, the most recent figure standing at $821.9 million for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 1.91% year-over-year to $821.9 million; the TTM figure through Mar 2026 stood at $821.9 million (down 1.91% YoY), while the FY2025 annual figure was $831.8 million, down 3.15% from the prior year.
- Cash & Current Investments was $821.9 million for Q1 2026 at Cronos, down from $831.8 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $981.5 million in Q1 2022 to a low of $821.9 million in Q1 2026.
- Historically, Cash & Current Investments has averaged $861.5 million across 5 years, with a median of $848.2 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Cash & Current Investments dropped 20.81% in 2022, then increased 2.68% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $877.7 million in 2022, then fell by 1.84% to $861.5 million in 2023, then slipped by 0.32% to $858.8 million in 2024, then fell by 3.15% to $831.8 million in 2025, then retreated by 1.19% to $821.9 million in 2026.
- The last three Cash & Current Investments figures came in at $821.9 million (Q1 2026), $831.8 million (Q4 2025), and $824.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | Cronos | 1.06 Bn | 292.44 Mn | 19.15 Mn | 821.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 821.86 Mn |
| Dec 31, 2025 | 831.79 Mn |
| Sep 30, 2025 | 824.17 Mn |
| Jun 30, 2025 | 834.42 Mn |
| Mar 31, 2025 | 837.82 Mn |
| Dec 31, 2024 | 858.81 Mn |
| Sep 30, 2024 | 862.03 Mn |
| Jun 30, 2024 | 848.19 Mn |
| Mar 31, 2024 | 855.11 Mn |
| Dec 31, 2023 | 861.53 Mn |
| Sep 30, 2023 | 839.56 Mn |
| Jun 30, 2023 | 840.94 Mn |
| Mar 31, 2023 | 836.43 Mn |
| Dec 31, 2022 | 877.72 Mn |
| Sep 30, 2022 | 888.75 Mn |
| Jun 30, 2022 | 944.90 Mn |
| Mar 31, 2022 | 981.47 Mn |
| Dec 31, 2021 | 1.00 Bn |
| Sep 30, 2021 | 1.04 Bn |
| Jun 30, 2021 | 1.10 Bn |